Abstract
Non-protein-bound iron (npb-iron), a potent prooxidant, is present in newborn plasma, and can induce peroxidation of surfactant (Moison et al, Lancet 1993;341:79). This study assessed the persistence of npb-iron (bleomycine assay) in 26 infants (GA; 26-34 wks) for the first 10 days of life. Npb-iron was present in 10 (38%), 7 (27%) and 2 (8%) infants at day 1, 4 and 10 respectively. In 5 babies npb-iron was not present at day 1 but developed at day 4, and in 2 of them it persisted until day 10. Npb-iron was more frequently present in the more immature babies (p<0.01) and in babies with a longer duration of O2 therapy (mean(SD): npb-iron pos 121.4 (174.8), npb-iron neg: 22.3 (40.0) hrs, p<0.01), whereas the level of the peroxidation product TBARS did not differ in infants with or without npb-iron. The babies who developed npb-iron at day 4 had a longer duration of O2 therapy than babies with npb-iron already present at day 1 (p<0.01). Npb-iron induced oxidative damage could play a role in the pathogenesis of acute and chronic lung disease in the newborn.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Zoeren-Grobben, D., Houdkamp, E., Moison, R. et al. THE PERSISTENCE OF NON-PROTEIN-BOUND PLASMA IRON IN PRETERM INFANTS. Pediatr Res 35, 280 (1994). https://doi.org/10.1203/00006450-199402000-00152
Issue Date:
DOI: https://doi.org/10.1203/00006450-199402000-00152